Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Start-Up Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

Add companies to Watchlist

45 companies were selected
Add Watchlist note (optional)

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

The invitation to claim the profile was originally sent to

or  

Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

Suggest Edits

Let us know what you think is inaccurate or missing.
We will check it out and update the profile if needed.

Claim Profile

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Already have an account? Login

Verify your email

We’ve sent a verification link to email@email.com
Reset password
Don't have an account? Sign up

Check your mailbox

We sent you an email with further instructions to
email@email.com

Do not forget to check your spam folder

Didn’t get the email? Resend email or Contact us

Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

Save Search

Search must have a valid name.
Search Was Saved

Rename Search

Search must have a valid name.
Search Was Saved
Delete Saved Search Confirmation
search will be permanently removed from Finder.
News Analysis
Search Startups

Tagged as ('autoimmune-diseases') Startups

Filters
Clear

Search by tag (1)

All of
Any of
None of

Sector 

Primary Sector 

Target Customer 

Core Technology 

Funding Stage 

Founded 

Total Raised 

Min
Max

Market Cap 

Min
Max

Business Models 

Product Stage 

Employees 

Location 

Status 

39 Startups 6 In the News 6 Recently Updated
  • Total Funding
    $1.19B
    Raised
    68
    Events
  • Private Funding
    $626.15M
    Raised
    35
    Rounds
  • Public Offerings
    $561.95M
    Raised
    31
    Offerings
  • M&A
    $0
    Raised
    2
    Deals

Funding

Rounds / Deals

Funding Stage

Number of Employees

Tags

There aren’t any companies that match your search
you can try looking for something else.

CytoReason logo

CytoReason

Machine Learning for Data-driven Target Discovery and Drug Development 2016 B2B 51-200 A $52M
laboratories
artificial-intelligence
healthcare-providers
patent-pending
drug-discovery
clinical-data
clinics
medical-technologies
prediction
data-analytics
digital-healthcare
big-data
pharma-companies
cancer
machine-learning
biotechnology
biopharmaceutical
immunotherapy
immunology
bioinformatics
mhealth
autoimmune-diseases
molecular-biology
decision-support
natural-language-processing
cells
coronavirus
Immunai logo

Immunai

Peripheral Tissue Analysis 2019 B2B 1-10 B $295M
immunotherapy
unicorn_2021
digital-healthcare
hospitals
immunology
data-analytics
actionable-insights
pharma-companies
cancer
autoimmune-diseases
artificial-intelligence
machine-learning
deep-learning
database
cells
Predicta Med logo

Predicta Med

Decision-support Platform for Early Detection and Intervention Selection of Autoimmune Diseases 2020 B2B 11-50 Seed $2.2M
recommendations
diagnostics
celiac-disease
emr
algorithms
autoimmune-diseases
decision-support
digital-healthcare
medical-data
artificial-intelligence
Gamida Cell logo

Gamida Cell

Public
Cellular and Immune Therapies 1998 B2B 51-200 Public $310.02M
medical-technologies
hospitals
biological-therapy
metabolic-disease
stem-cells
cancer
therapeutics
oncology
hematology
doctors
healthcare-providers
pharma-companies
cell-therapy
regenerative-medicine
autoimmune-diseases
treatments
BiomX logo

BiomX

Public
Microbiome Therapies for Chronic Diseases 2015 B2B 51-200 Public $81.5M
bioconvergence
patients
inflammatory-diseases
cancer
targeted-therapy
microbiology
pharmaceuticals
dermatology
microbiome
bacteria
artificial-intelligence
drug-discovery
genomics
machine-learning
biomarkers
autoimmune-diseases
acne
Enlivex Therapeutics R&D logo

Enlivex Therapeutics R&D

Public
Macrophage Reprogramming Cell Therapies for Life-threatening Diseases 2005 B2B 11-50 Public $72.2M
cell-therapy
inflammatory-diseases
crohn's-disease
pharmaceuticals
cancer
immunology
coronavirus
immunotherapy
pharma-companies
chronic-patients
patients
autoimmune-diseases
OBCTCD24 logo

OBCTCD24

Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
For more details, you can read our .
Exosome-delivered CD24-based Therapeutics 2020 B2B 1-10 Pre-Funding Undisclosed
autoimmune-diseases
pharmaceuticals
healthcare-providers
drug-development
biopharmaceutical
coronavirus
respiratory
therapeutics
biotechnology
inhalation

Search Startups

39 Results
  • Total Funding
    $1.19B
    Raised
    68
    Events
  • Private Funding
    $626.15M
    Raised
    35
    Rounds
  • Public Offerings
    $561.95M
    Raised
    31
    Offerings
  • M&A
    $0
    Raised
    2
    Deals

Funding

Rounds / Deals

Funding Stage

Number of Employees

There aren’t any companies that match your search
you can try looking for something else.

CytoReason logo
Raised
$52M
CytoReason
Machine Learning for Data-driven Target Discovery and Drug Development
Founded:2016
Business Model:B2B
Employees:51-200
Funding Stage:A
Immunai logo
Raised
$295M
Immunai
Peripheral Tissue Analysis
Founded:2019
Business Model:B2B
Employees:1-10
Funding Stage:B
Predicta Med logo
Raised
$2.2M
Predicta Med
Decision-support Platform for Early Detection and Intervention Selection of Autoimmune Diseases
Founded:2020
Business Model:B2B
Employees:11-50
Funding Stage:Seed
Gamida Cell logo
Raised
$310.02M
Gamida Cell
Public
Cellular and Immune Therapies
Founded:1998
Business Model:B2B
Employees:51-200
Funding Stage:Public
BiomX logo
Raised
$81.5M
BiomX
Public
Microbiome Therapies for Chronic Diseases
Founded:2015
Business Model:B2B
Employees:51-200
Funding Stage:Public
Enlivex Therapeutics R&D logo
Raised
$72.2M
Enlivex Therapeutics R&D
Public
Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
Founded:2005
Business Model:B2B
Employees:11-50
Funding Stage:Public
OBCTCD24 logo
Raised
Undisclosed
OBCTCD24
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
For more details, you can read our .
Exosome-delivered CD24-based Therapeutics
Founded:2020
Business Model:B2B
Employees:1-10
Funding Stage:Pre-Funding
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
  • Get unlimited search results
  • Save to custom lists - Watchlists
  • Get notified with news and updates
  • Connect with people
And much more...
I already have access,
I already have access,